Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers
NCT04225052Phase 1Completed
- Sponsor
- Yuhan
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YHP1903 in nicotine dependence (2 arms), sponsored by Yuhan. Primary endpoints: Area Under the Curve to the last measurable concentration and Maximum Plasma Concentration. Started Dec 2019; status: completed.
02
Drugs
YHP1903
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04225052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04225052.